Hasan, Tayyaba
![Sudoc [ABES], France](/viaf/images/flags/SUDOC.png "Sudoc [ABES], France")
Tayyaba Hasan American dermatologist and researcher
VIAF ID: 68776046 (Personal)
Permalink: http://viaf.org/viaf/68776046
Preferred Forms
-
100 1 _
‡a
Hasan, Tayyaba
-
100 1 _
‡a
Hasan, Tayyaba
-
100 1 _
‡a
Hasan, Tayyaba
-
100 1 _ ‡a Hasan, Tayyaba
-
100 1 _
‡a
Hasan, Tayyaba
-
100 1 _ ‡a Hasan, Tayyaba
-
100 1 _ ‡a Hasan, Tayyaba
-
100 1 _
‡a
Hasan, Tayyaba
-
100 0 _
‡a
Tayyaba Hasan
‡c
American dermatologist and researcher
4xx's: Alternate Name Forms (2)
Works
| Title | Sources |
|---|---|
| Advances in photochemotherapy : 6-7 September 1988, Boston, Massachusetts |
|
| Cabozantinib Inhibits Photodynamic Therapy-Induced Auto- and Paracrine MET Signaling in Heterotypic Pancreatic Microtumors |
|
| CT contrast predicts pancreatic cancer treatment response to verteporfin-based photodynamic therapy |
|
| Development and applications of photo-triggered theranostic agents |
|
| Effects of photodynamic therapy with topical application of 5-aminolevulinic acid on normal skin of hairless guinea pigs |
|
| Epidermal growth factor receptor-targeted photosensitizer selectively inhibits EGFR signaling and induces targeted phototoxicity in ovarian cancer cells |
|
| Exploiting a bacterial drug-resistance mechanism: a light-activated construct for the destruction of MRSA. |
|
| Flow induces epithelial-mesenchymal transition, cellular heterogeneity and biomarker modulation in 3D ovarian cancer nodules |
|
| High vascular delivery of EGF, but low receptor binding rate is observed in AsPC-1 tumors as compared to normal pancreas. |
|
| Image-Based Quantification of Benzoporphyrin Derivative Uptake, Localization, and Photobleaching in 3D Tumor Models, for Optimization of PDT Parameters |
|
| An imaging-based platform for high-content, quantitative evaluation of therapeutic response in 3D tumour models |
|
| Improved tumor contrast achieved by single time point dual-reporter fluorescence imaging. |
|
| In vivo quantification of tumor receptor binding potential with dual-reporter molecular imaging |
|
| Killing hypoxic cell populations in a 3D tumor model with EtNBS-PDT |
|
| Low-cost photodynamic therapy devices for global health settings: Characterization of battery-powered LED performance and smartphone imaging in 3D tumor models |
|
| Mechanisms and techniques in photodynamic therapy XXI |
|
| Membrane composition is a functional determinant of NIR-activable liposomes in orthotopic head and neck cancer |
|
| Neoadjuvant photodynamic therapy augments immediate and prolonged oxaliplatin efficacy in metastatic pancreatic cancer organoids. |
|
| NIR Photodynamic Destruction of PDAC and HNSCC Nodules Using Triple-Receptor-Targeted Photoimmuno-Nanoconjugates: Targeting Heterogeneity in Cancer |
|
| Photodynamic medicine : from bench to clinic |
|
| Photodynamic therapy of arteries. A novel approach for treatment of experimental intimal hyperplasia |
|
| Photoincorporation of tetracycline into Escherichia coli ribosomes. Identification of the major proteins photolabeled by native tetracycline and tetracycline photoproducts and implications for the inhibitory action of tetracycline on protein synthes |
|
| PuraMatrix encapsulation of cancer cells |
|
| Quantitative imaging reveals heterogeneous growth dynamics and treatment-dependent residual tumor distributions in a three-dimensional ovarian cancer model |
|
| Rapid Functional Definition of Extended Spectrumβ‐Lactamase Activity in Bacterial CulturesviaCompetitive Inhibition of Fluorescent Substrate Cleavage |
|
| Selective treatment and monitoring of disseminated cancer micrometastases in vivo using dual-function, activatable immunoconjugates |
|
| Shining light on the dark side of imaging: excited state absorption enhancement of a bis-styryl BODIPY photoacoustic contrast agent |
|
| Synergistic enhancement of carboplatin efficacy with photodynamic therapy in a three-dimensional model for micrometastatic ovarian cancer |
|
